Completed PHASE4 INTERVENTIONAL 3-arm NCT00517725

Nebivolol Versus Bisoprolol Versus Carvedilol in Heart Failure (CARNEBI)

Nebivolol Versus Bisoprolol Versus Carvedilol in Heart Failure: Effects on Exercise Capacity and Hypoxia, Chemoreceptor Response, Pulmonary Function

Sponsor: Centro Cardiologico Monzino

Conditions Chronic Heart Failure

Interventions Nebivolol bisoprolol carvedilol

Updated 5 times since 2017 Last updated: Sep 15, 2010 Started: Jul 31, 2007 Completion: May 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Chronic Heart Failure and is currently completed. Centro Cardiologico Monzino leads this study, which shows 5 recorded versions since 2007 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jul 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centro Cardiologico Monzino

Data source: Centro Cardiologico Monzino

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Milan, Italy